NL7700054A - THE INVENTION RELATES TO A PROCESS FOR THE PREPARATION OF NEW PREGNAAN AND AN-DROSTAN Derivatives. - Google Patents

THE INVENTION RELATES TO A PROCESS FOR THE PREPARATION OF NEW PREGNAAN AND AN-DROSTAN Derivatives.

Info

Publication number
NL7700054A
NL7700054A NL7700054A NL7700054A NL7700054A NL 7700054 A NL7700054 A NL 7700054A NL 7700054 A NL7700054 A NL 7700054A NL 7700054 A NL7700054 A NL 7700054A NL 7700054 A NL7700054 A NL 7700054A
Authority
NL
Netherlands
Prior art keywords
pregnaan
drostan
derivatives
preparation
new
Prior art date
Application number
NL7700054A
Other languages
Dutch (nl)
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of NL7700054A publication Critical patent/NL7700054A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0088—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing unsubstituted amino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/0025—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16
    • C07J7/003—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL7700054A 1976-01-06 1977-01-05 THE INVENTION RELATES TO A PROCESS FOR THE PREPARATION OF NEW PREGNAAN AND AN-DROSTAN Derivatives. NL7700054A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB357/76A GB1570394A (en) 1976-01-06 1976-01-06 11-acyloxy-3-hydroxy steroids

Publications (1)

Publication Number Publication Date
NL7700054A true NL7700054A (en) 1977-07-08

Family

ID=9702974

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7700054A NL7700054A (en) 1976-01-06 1977-01-05 THE INVENTION RELATES TO A PROCESS FOR THE PREPARATION OF NEW PREGNAAN AND AN-DROSTAN Derivatives.

Country Status (12)

Country Link
JP (1) JPS5285159A (en)
AU (1) AU513579B2 (en)
BE (1) BE850108A (en)
CA (1) CA1084903A (en)
DE (1) DE2700267A1 (en)
DK (1) DK3577A (en)
FR (1) FR2361419A1 (en)
GB (1) GB1570394A (en)
NL (1) NL7700054A (en)
NZ (1) NZ183004A (en)
SE (1) SE7700098L (en)
ZA (1) ZA7759B (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ300694A3 (en) * 1993-12-02 1996-05-15 Akzo Nobel Nv Substituted 2beta-morpholinandrostane derivatives, process of their preparation, their use for preparing pharmaceutical preparations and pharmaceutical compositions containing thereof
GB0105772D0 (en) * 2001-03-08 2001-04-25 Sterix Ltd Use
WO2013056181A1 (en) 2011-10-14 2013-04-18 Sage Therapeutics, Inc. 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof
RS59734B1 (en) 2012-01-23 2020-02-28 Sage Therapeutics Inc Neuroactive steroid formulations comprising a complex of allopregnanolone and sulfobutyl ether beta-cyclodextrin
US20140057885A1 (en) 2012-08-21 2014-02-27 Sage Therapeutics, Inc. Methods of treating epilepsy or status epilepticus
JP6239091B2 (en) 2013-04-17 2017-11-29 セージ セラピューティクス， インコーポレイテッド 19-nor neurostimulatory steroids and methods of use thereof
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
CN118754924A (en) 2013-04-17 2024-10-11 萨奇治疗股份有限公司 19-NorC 3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
DK3021852T3 (en) * 2013-07-19 2021-03-15 Sage Therapeutics Inc NEUROACTIVE STEROIDS, COMPOSITIONS AND USES
ES2706180T3 (en) 2013-08-23 2019-03-27 Sage Therapeutics Inc Neuroactive steroids, compositions and uses thereof
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
JOP20200195A1 (en) 2014-09-08 2017-06-16 Sage Therapeutics Inc Neuroactive steroids, compositions, and uses thereof
CN118344424A (en) 2014-10-16 2024-07-16 萨奇治疗股份有限公司 Compositions and methods for targeting CNS disorders
LT3206493T (en) 2014-10-16 2020-08-25 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
PT3224269T (en) 2014-11-27 2020-06-01 Sage Therapeutics Inc Compositions and methods for treating cns disorders
SI3250210T1 (en) 2015-01-26 2021-07-30 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
ES2935476T3 (en) 2015-02-20 2023-03-07 Sage Therapeutics Inc Neuroactive steroids, compositions and uses thereof
EP3725213A1 (en) 2015-06-10 2020-10-21 Boston Scientific Scimed Inc. Bodily substance detection by evaluating photoluminescent response to excitation radiation
RU2766155C2 (en) 2016-03-08 2022-02-08 Сейдж Терапьютикс, Инк. Neuroactive steroids, compositions and applications thereof
CN109689673B (en) 2016-07-11 2023-03-14 萨奇治疗股份有限公司 C17, C20 and C21 substituted neuroactive steroids and methods of use thereof
US20190233465A1 (en) 2016-07-11 2019-08-01 Sage Therapeutics, Inc. C7, c12, and c16 substituted neuroactive steroids and their methods of use
BR112020012761A2 (en) * 2017-12-22 2021-02-17 Sage Therapeutics, Inc. compositions and methods for the treatment of snc disorders
US20230322846A9 (en) 2018-12-05 2023-10-12 Sage Therapeutics, Inc. Neuroactive steroids and their methods of use
EP3976628A1 (en) 2019-05-31 2022-04-06 Sage Therapeutics, Inc. Neuroactive steroids and compositions thereof
BR112021026445A2 (en) * 2019-06-27 2022-03-08 Sage Therapeutics Inc Compositions and Methods for Treating CNS Disorders
TW202114696A (en) * 2019-06-27 2021-04-16 美商賽吉醫療公司 Compositions and methods for treating cns disorders

Also Published As

Publication number Publication date
ZA7759B (en) 1978-02-22
JPS5285159A (en) 1977-07-15
FR2361419A1 (en) 1978-03-10
SE7700098L (en) 1977-07-07
BE850108A (en) 1977-07-05
AU2106577A (en) 1978-07-13
GB1570394A (en) 1980-07-02
NZ183004A (en) 1980-03-05
DE2700267A1 (en) 1977-07-14
FR2361419B1 (en) 1980-04-04
AU513579B2 (en) 1980-12-11
DK3577A (en) 1977-07-07
CA1084903A (en) 1980-09-02

Similar Documents

Publication Publication Date Title
NL7700054A (en) THE INVENTION RELATES TO A PROCESS FOR THE PREPARATION OF NEW PREGNAAN AND AN-DROSTAN Derivatives.
NL7609439A (en) PROCESS FOR THE PREPARATION OF NEW HETEROCYCLICAL COMPOUNDS.
NL7705738A (en) PROCESS FOR THE PREPARATION OF NEW PHARMACECUTICAL PREPARATIONS.
NL7701568A (en) PROCESS FOR THE PREPARATION OF NEW CEPHALOSPORIN DERIVATIVES.
NL7710840A (en) PROCESS FOR THE PREPARATION OF NEW 1-ARYL-OXY-2-HYDROXY-3-ALKYLENEAMINOPROPANES
NL7508824A (en) PROCESS FOR THE PREPARATION OF NEW CHINAZOLINE DERIVATIVES.
NL7707192A (en) PROCESS FOR THE PREPARATION OF A NEW ETS COMPOSITION.
NL7602191A (en) PROCESS FOR THE PREPARATION OF NEW PIPERAZI NYLIMINORIFAMYCINS.
NL7702171A (en) PROCESS FOR THE PREPARATION OF A PREPARATION FOR THE TREATMENT OF BURNS.
NL7703503A (en) PROCESS FOR THE PREPARATION OF NEW PROSTAG-LANDIN DERIVATIVES.
NL7509913A (en) PROCESS FOR THE PREPARATION OF NEW BENZISO-QUINOLINE DERIVATIVES.
NL7606825A (en) PROCESS FOR THE PREPARATION OF NEW PROSTAGLANDIN DERIVATIVES.
NL7604833A (en) PROCESS FOR THE PREPARATION OF NEW 1-SUBSTITUATED 4-AROYL-4-HYDROXYPIPERIDINS.
NL7609485A (en) PROCESS FOR THE PREPARATION OF NEW N-TETRA-HYDROFURFURYL NOROXYMORPHONES.
NL7610513A (en) PROCESS FOR THE PREPARATION OF NEW N-ARYL-N- (1-L-4-PIPERIDINYL) ARYLACEETAMIDES.
NL7602192A (en) PROCESS FOR THE PREPARATION OF NEW SUBSTITUTED PIPERAZINYLIMINORIFAMYCINS.
NL7612031A (en) PROCESS FOR THE PREPARATION OF NEW QINOLINE DERIVATIVES.
NL7603629A (en) PROCESS FOR THE PREPARATION OF NEW ALKYL-AMINO-ERYTHROMYCINS AND THEIR SALTS.
NL7712431A (en) PROCESS FOR THE PREPARATION OF NEW NORBORNA DERIVATIVES.
NL7709736A (en) NEW PROCESS FOR THE PREPARATION OF CHINAZOLINE DERIVATIVES.
NL7609020A (en) PROCESS FOR THE PREPARATION OF NEW CEPHALOSPORIN DERIVATIVES.
NL7705939A (en) NEW PROCESS FOR THE PREPARATION OF SUBSTITUTED AMINOCHINAZOLINE DERIVATIVES.
BE846473A (en) PROCESS FOR THE PREPARATION OF NEW N-ARYL-N- (1-L-4-PIPERIDINYL) -ARYL ACEETAMIDES
NL7711577A (en) PROCESS FOR THE PREPARATION OF NEW CLAVAM DERIVATIVES.
NL7609539A (en) PROCESS FOR THE PREPARATION OF NEW PENICILLINS AND CEPHALOSSPORINS.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BV The patent application has lapsed